Janus kinase 3 inhibitor - Wikipedia
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache? | SpringerLink
JAK Inhibitor 瑞石生物医药有限公司
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
:max_bytes(150000):strip_icc()/jak-inhibitors-4706526-FINAL-3461d4fc6ce44f54801ef59489afa62c.png "JAK Inhibitors: Uses, Drug Options, and Side Effects")
JAK Inhibitors: Uses, Drug Options, and Side Effects
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
JAK Inhibitor I | CAS 457081-03-7 | SCBT - Santa Cruz Biotechnology
Janus kinase inhibitors in dermatology: Part II. A comprehensive review - Journal of the American Academy of Dermatology
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
Current and future status of JAK inhibitors - The Lancet
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
Dermatologiske patienter kan vente sig meget af JAK-hæmmere
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis - Nash - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19 | Science Immunology
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
